Cargando…
Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
Sarcopenia, which represents the degenerative and systemic loss of skeletal muscle mass, is a multifactorial syndrome caused by various clinical conditions. Sarcopenia reflects not only frailty and poor general health status, but also the possible presence of advanced or progressive cancer or cancer...
Autores principales: | Fukushima, Hiroshi, Fujii, Yasuhisa, Koga, Fumitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387186/ https://www.ncbi.nlm.nih.gov/pubmed/30754663 http://dx.doi.org/10.3390/ijms20030760 |
Ejemplares similares
-
Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2015) -
Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
por: Fukushima, Hiroshi, et al.
Publicado: (2016) -
Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma
por: Une, Minami, et al.
Publicado: (2022) -
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
por: Fukushima, Hiroshi, et al.
Publicado: (2018) -
Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review
por: Fukushima, Hiroshi, et al.
Publicado: (2022)